United Health Products, Inc. (OTCQB:
UEEC) today announced the hiring of New York City based ProActive
Capital Group, LLC (PCG), a leading capital markets advisory and
communication strategies firm, to assist with achieving investor and
corporate awareness.
PCG assists emerging and developing companies to achieve financial
objectives through active, multi-channel engagement with investors to
facilitate dialogue with the investment community and public at large.
“We are familiar with the quality of work and investor access that
ProActive Capital provides and believe they are wonderfully suited to
deliver our message to the community of investors seeking to profit from
the healthcare and wound care sectors,” stated Doug K. Beplate, COO of
United Health Products. “Their multi-channel approach makes them a good
match for our investor awareness needs and we look forward to updating
our shareholders as we move forward.”
“United Health Products’ unique, patented hemostatic gauze and its
significant market penetration potential in the healthcare and wound
care sectors was clear to us from the beginning of our discussions, and
we are pleased to be able to bring this opportunity to our community of
investors, media, and trade professionals,” commented Jeff Ramson, CEO
of ProActive Capital Group. "We look forward to working with their team
and broadening and enhancing United Health’s exposure through our
network."
About United Health Products, Inc.
United Health Products, Inc. (UEEC) develops, manufactures and markets a
patented hemostatic gauze, for the healthcare and wound care sectors.
The product, HemoStyp®, is derived from regenerated oxidized cellulose,
which is all natural, and designed to absorb exudate/drainage from
superficial wounds and helps control bleeding. UEEC is focused on
identifying new markets and applications for its product as well as
ramping up sales in its current markets. For more on United Health
Products, Inc. visit: www.unitedhealthproductsinc.com
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act
of 1995: This news release may contain forward-looking information
within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended, including statements that include the words "believes,"
"expects," "anticipates" or similar expressions. Such forward-looking
statements involve known and unknown risks, uncertainties and other
factors that may cause the actual results, performance or achievements
of the Company to differ materially from those expressed or implied by
such forward-looking statements.
Copyright Business Wire 2014